doi: 10.3389/fonc.2025.1698320 Received 03 September 2025 Revised 19 November 2025 Accepted 24 November 2025 Published 10 December 2025 Volume 15 - 2025 Edited by Mansoor-Ali Vaali-Mohammed, King Saud University, Saudi Arabia Reviewed by Veenita Khare, University of California, San Diego, United States Rasoul Mirzaei, Hamadan University of Medical Sciences, Iran Erwin Julian, Universitas Indonesia Fakultas Kedokteran, Indonesia Updates Copyright 2025 Yang, Liu, Zou, Liu, Zhou, Tao and Liu
Schneider, S
Why Tesamorelin May Be a Better Clinical Conversation Tesamorelin is FDA approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy, but it is not indicated for general weight loss management
NAD + forms are the major electron carriers in cellular metabolic reactions
Glossitis and mouth ulcers , where the tongue appears swollen or unusually smooth